Display options
Share it on

Cancers (Basel). 2021 Aug 28;13(17). doi: 10.3390/cancers13174353.

Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer.

Cancers

Viktoriia Cherkasova, Olga Kovalchuk, Igor Kovalchuk

Affiliations

  1. Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 7X8, Canada.

PMID: 34503163 PMCID: PMC8430689 DOI: 10.3390/cancers13174353

Abstract

Despite the multiple preventive measures and treatment options, colorectal cancer holds a significant place in the world's disease and mortality rates. The development of novel therapy is in critical need, and based on recent experimental data, cannabinoids could become excellent candidates. This review covered known experimental studies regarding the effects of cannabinoids on intestinal inflammation and colorectal cancer. In our opinion, because colorectal cancer is a heterogeneous disease with different genomic landscapes, the choice of cannabinoids for tumor prevention and treatment depends on the type of the disease, its etiology, driver mutations, and the expression levels of cannabinoid receptors. In this review, we describe the molecular changes of the endocannabinoid system in the pathologies of the large intestine, focusing on inflammation and cancer.

Keywords: cannabinoids; colorectal cancer; intestinal inflammation

References

  1. Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12192-12197 - PubMed
  2. Channels (Austin). 2019 Dec;13(1):162-167 - PubMed
  3. Cancers (Basel). 2019 Jun 05;11(6): - PubMed
  4. Br J Pharmacol. 2016 May;173(10):1678-92 - PubMed
  5. Gut. 2005 Dec;54(12):1741-50 - PubMed
  6. PLoS One. 2015 Dec 03;10(12):e0144270 - PubMed
  7. Eur J Pharm Sci. 2015 Sep 18;77:180-8 - PubMed
  8. Int J Cancer. 2018 Jan 1;142(1):121-132 - PubMed
  9. Science. 2015 Jan 2;347(6217):78-81 - PubMed
  10. Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G364-71 - PubMed
  11. Front Pharmacol. 2016 Oct 04;7:341 - PubMed
  12. Oncoscience. 2015 Feb 09;2(2):131-41 - PubMed
  13. Cancer Lett. 2011 Aug 1;307(1):6-17 - PubMed
  14. J Mol Med (Berl). 2008 Jan;86(1):89-98 - PubMed
  15. Cancer Res. 2000 Jul 1;60(13):3333-7 - PubMed
  16. Mediators Inflamm. 2013;2013:549627 - PubMed
  17. Blood Cancer J. 2015 Dec 04;5:e373 - PubMed
  18. J Biol Chem. 1983 Aug 10;258(15):9302-6 - PubMed
  19. Nature. 1987 May 28-Jun 3;327(6120):293-7 - PubMed
  20. World J Gastroenterol. 2007 Aug 7;13(29):3985-9 - PubMed
  21. Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19144-9 - PubMed
  22. Cancers (Basel). 2019 May 22;11(5): - PubMed
  23. Int J Cancer. 2007 Nov 15;121(10):2172-80 - PubMed
  24. PPAR Res. 2007;2007:23513 - PubMed
  25. Br J Pharmacol. 2002 Jun;136(3):452-8 - PubMed
  26. Gastroenterology. 1994 Oct;107(4):1183-8 - PubMed
  27. Biochem J. 2012 Feb 1;441(3):789-802 - PubMed
  28. Br J Pharmacol. 2010 Jun;160(3):712-23 - PubMed
  29. Br J Pharmacol. 1992 Jun;106(2):231-2 - PubMed
  30. Gut. 2016 Mar;65(3):426-36 - PubMed
  31. Br J Pharmacol. 2011 Aug;163(7):1479-94 - PubMed
  32. CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):7-16 - PubMed
  33. Br J Pharmacol. 2012 Jun;166(4):1444-60 - PubMed
  34. Science. 2006 Sep 29;313(5795):1960-4 - PubMed
  35. Eur J Pharmacol. 2008 Sep 4;591(1-3):128-31 - PubMed
  36. Med Sci (Basel). 2018 Apr 13;6(2): - PubMed
  37. Evid Based Complement Alternat Med. 2020 Jul 20;2020:2371527 - PubMed
  38. Cancer Res. 2004 Mar 15;64(6):1943-50 - PubMed
  39. Clin Cancer Res. 2009 Apr 1;15(7):2248-58 - PubMed
  40. Biol Pharm Bull. 2012;35(6):924-32 - PubMed
  41. Phytother Res. 2018 Nov;32(11):2191-2201 - PubMed
  42. Chem Biol Interact. 2018 Oct 1;294:128-134 - PubMed
  43. PLoS One. 2013 Oct 21;8(10):e76918 - PubMed
  44. Immunogenetics. 2006 Sep;58(9):714-25 - PubMed
  45. J Clin Invest. 2007 May;117(5):1175-83 - PubMed
  46. Cancer Res. 2008 Aug 1;68(15):6468-76 - PubMed
  47. Handb Exp Pharmacol. 2015;231:423-47 - PubMed
  48. Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):33-49 - PubMed
  49. Inflamm Bowel Dis. 2009 Nov;15(11):1678-85 - PubMed
  50. Gastroenterology. 1994 Aug;107(2):420-8 - PubMed
  51. Br J Pharmacol. 2013 Jun;169(4):784-93 - PubMed
  52. PLoS One. 2010 Jan 14;5(1):e8702 - PubMed
  53. Br J Pharmacol. 2008 Jan;153(2):199-215 - PubMed
  54. Clin Cancer Res. 2008 Dec 1;14(23):7691-700 - PubMed
  55. Prostaglandins Leukot Essent Fatty Acids. 1993 Jun;48(6):429-37 - PubMed
  56. Nat Rev Endocrinol. 2016 Mar;12(3):133-43 - PubMed
  57. J Addict. 2015;2015:707596 - PubMed
  58. Cancers (Basel). 2019 May 09;11(5): - PubMed
  59. Nat Rev Cancer. 2013 Jan;13(1):51-65 - PubMed
  60. J Neuroimmune Pharmacol. 2006 Mar;1(1):50-64 - PubMed
  61. Cancer Lett. 2019 Apr 10;447:12-23 - PubMed
  62. J Neurosci. 2011 Jan 26;31(4):1489-99 - PubMed
  63. Nature. 1996 Nov 7;384(6604):83-7 - PubMed
  64. Cell. 1996 Nov 29;87(5):803-9 - PubMed
  65. Oncogene. 2009 Nov 5;28(44):3892-902 - PubMed
  66. World J Gastroenterol. 2008 Jul 7;14(25):3937-47 - PubMed
  67. Nat Rev Neurol. 2020 Jan;16(1):9-29 - PubMed
  68. Sci Rep. 2017 Nov 15;7(1):15645 - PubMed
  69. Oncogene. 2000 Nov 16;19(48):5517-24 - PubMed
  70. Trends Pharmacol Sci. 2007 Jan;28(1):39-45 - PubMed
  71. J Immunol. 2019 Apr 15;202(8):2360-2371 - PubMed
  72. CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed
  73. Br J Pharmacol. 2004 Aug;142(8):1247-54 - PubMed
  74. Lipids. 2008 Oct;43(10):887-94 - PubMed
  75. Cell. 1998 Mar 6;92(5):645-56 - PubMed
  76. Expert Rev Anticancer Ther. 2008 Apr;8(4):561-72 - PubMed
  77. J Clin Invest. 2004 Apr;113(8):1202-9 - PubMed
  78. Aliment Pharmacol Ther. 2005 Oct 15;22(8):667-83 - PubMed
  79. Brain Behav Immun. 2017 Jan;59:10-20 - PubMed
  80. J Neurosci. 1999 May 15;19(10):3773-80 - PubMed
  81. Br J Pharmacol. 2007 Nov;152(5):815-24 - PubMed
  82. PLoS One. 2011;6(12):e28159 - PubMed
  83. Br J Pharmacol. 2008 Feb;153(3):410-9 - PubMed
  84. Nat Rev Cancer. 2009 Nov;9(11):798-809 - PubMed
  85. Neurogastroenterol Motil. 2010 Mar;22(3):350-e88 - PubMed
  86. Curr Oncol. 2016 Dec;23(6):398-406 - PubMed
  87. Br J Pharmacol. 2007 Dec;152(7):1092-101 - PubMed
  88. Pharmacol Rev. 2006 Sep;58(3):389-462 - PubMed
  89. Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:619-31 - PubMed
  90. Br J Pharmacol. 2010 Jan;159(1):129-41 - PubMed
  91. J Inflamm (Lond). 2020 Apr 21;17:15 - PubMed
  92. Eur J Pharmacol. 1996 Feb 5;296(3):347-50 - PubMed
  93. Inflamm Bowel Dis. 2019 May 4;25(6):1006-1018 - PubMed
  94. J Crohns Colitis. 2014 Sep;8(9):998-1009 - PubMed
  95. Proc Natl Acad Sci U S A. 2001 May 22;98(11):6407-11 - PubMed
  96. Cells. 2014 Feb 19;3(1):112-28 - PubMed
  97. Oncol Lett. 2013 Mar;5(3):870-876 - PubMed
  98. Eur J Pharmacol. 2003 Jan 1;458(1-2):207-15 - PubMed
  99. Pharmacol Ther. 2007 Apr;114(1):13-33 - PubMed
  100. Gastroenterology. 2005 Aug;129(2):437-53 - PubMed
  101. FASEB J. 2004 Feb;18(2):300-10 - PubMed
  102. Biochim Biophys Acta. 1995 Sep 14;1258(2):215-23 - PubMed
  103. Nature. 2015 Nov 19;527(7578):329-35 - PubMed
  104. J Biol Chem. 2002 Nov 22;277(47):44877-85 - PubMed
  105. Eur J Histochem. 2015 May 05;59(2):2481 - PubMed
  106. Pharmacol Res. 2017 May;119:227-236 - PubMed
  107. Gut. 2006 Oct;55(10):1373-6 - PubMed
  108. Drug Discov Today. 2014 Oct;19(10):1632-9 - PubMed
  109. Br J Pharmacol. 2001 Oct;134(3):563-70 - PubMed
  110. Cell. 1990 Jun 1;61(5):759-67 - PubMed
  111. Cell. 2013 Jul 18;154(2):274-84 - PubMed
  112. J Neurosci. 1995 Oct;15(10):6552-61 - PubMed
  113. Nat Rev Drug Discov. 2008 May;7(5):438-55 - PubMed
  114. Proc Natl Acad Sci U S A. 2017 May 9;114(19):5005-5010 - PubMed
  115. Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):690-704 - PubMed
  116. Oncogene. 2019 Jun;38(24):4788-4803 - PubMed
  117. Cancer Causes Control. 2015 Sep;26(9):1271-1279 - PubMed
  118. Nature. 2002 Jun 27;417(6892):949-54 - PubMed
  119. Nature. 2017 Sep 7;549(7670):48-53 - PubMed
  120. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):173-92 - PubMed
  121. J Immunol. 2010 Nov 1;185(9):5236-46 - PubMed
  122. Pain. 2006 Sep;124(1-2):175-83 - PubMed
  123. Trends Immunol. 2002 Mar;23(3):144-50 - PubMed
  124. Nat Med. 2007 Jan;13(1):35-7 - PubMed
  125. Cannabis Cannabinoid Res. 2018 Dec 21;3(1):272-281 - PubMed
  126. Curr Opin Pharmacol. 2007 Dec;7(6):575-82 - PubMed
  127. Biomed Environ Mass Spectrom. 1987 Sep;14(9):495-9 - PubMed
  128. Br J Pharmacol. 2004 Jun;142(3):495-500 - PubMed
  129. Carcinogenesis. 2014 Dec;35(12):2787-97 - PubMed
  130. Cancer Immunol Immunother. 2004 Aug;53(8):723-8 - PubMed
  131. Front Physiol. 2012 May 22;3:149 - PubMed
  132. Genes Dis. 2016 Jun;3(2):130-143 - PubMed
  133. Cannabis Cannabinoid Res. 2017 Jul 01;2(1):167-182 - PubMed
  134. Am J Ther. 2007 Sep-Oct;14(5):475-83 - PubMed
  135. Carcinogenesis. 2010 May;31(5):794-803 - PubMed
  136. J Biol Chem. 2005 Jul 29;280(30):27879-87 - PubMed
  137. Curr Neuropharmacol. 2016;14(8):935-951 - PubMed
  138. Cannabis Cannabinoid Res. 2018 Jun 01;3(1):120-135 - PubMed
  139. Science. 1992 Dec 18;258(5090):1946-9 - PubMed
  140. Mol Pharmacol. 1998 Nov;54(5):834-43 - PubMed
  141. Nat Commun. 2014 Dec 05;5:5648 - PubMed
  142. Br J Pharmacol. 2008 Jan;153(2):263-70 - PubMed
  143. Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13345-50 - PubMed
  144. Cell Tissue Res. 2000 Oct;302(1):73-80 - PubMed
  145. Gastroenterology. 2012 Apr;142(4):855-864.e8 - PubMed
  146. Nat Rev Cancer. 2004 Aug;4(8):604-16 - PubMed
  147. Science. 2012 Aug 10;337(6095):730-5 - PubMed
  148. Cancer. 2015 Sep 15;121(18):3281-9 - PubMed
  149. Lancet Oncol. 2005 Jan;6(1):35-42 - PubMed
  150. J Neuroimmune Pharmacol. 2012 Dec;7(4):856-65 - PubMed
  151. Clin Gastroenterol Hepatol. 2012 Jun;10(6):639-45 - PubMed
  152. Br J Pharmacol. 2012 Nov;167(6):1218-31 - PubMed
  153. Gastroenterology. 2003 Sep;125(3):677-87 - PubMed
  154. Gut. 2009 Aug;58(8):1091-103 - PubMed
  155. PLoS One. 2011;6(8):e23003 - PubMed
  156. Mol Endocrinol. 2011 Nov;25(11):1835-48 - PubMed
  157. Scand J Gastroenterol. 2008 Jan;43(1):66-72 - PubMed
  158. Apoptosis. 2014 Jun;19(6):1029-42 - PubMed
  159. Nat Rev Immunol. 2005 May;5(5):400-11 - PubMed
  160. Eur J Pharmacol. 2016 Mar 15;775:1-14 - PubMed
  161. J Comp Neurol. 2003 Oct 6;465(1):121-35 - PubMed
  162. Nat Rev Cancer. 2003 Jan;3(1):46-54 - PubMed
  163. Cell Mol Life Sci. 2005 Mar;62(6):708-16 - PubMed
  164. Drug Metab Rev. 2014 Feb;46(1):86-95 - PubMed
  165. Phytomedicine. 2014 Apr 15;21(5):631-9 - PubMed
  166. Mol Biosyst. 2010 Aug;6(8):1411-8 - PubMed
  167. Nat Rev Cancer. 2012 May 04;12(6):436-44 - PubMed
  168. Gastroenterology. 2016 Aug;151(2):252-66 - PubMed
  169. Nature. 1994 Dec 15;372(6507):686-91 - PubMed
  170. Diabetes. 2007 Jul;56(7):1761-72 - PubMed
  171. Mol Syst Biol. 2010 Jul;6:392 - PubMed
  172. J Neurochem. 2005 Oct;95(2):437-45 - PubMed
  173. J Cell Sci. 2010 May 15;123(Pt 10):1603-11 - PubMed
  174. World J Gastroenterol. 2011 Jul 14;17(26):3092-100 - PubMed
  175. Gut. 2008 Aug;57(8):1140-55 - PubMed
  176. Oncogene. 2009 Feb 26;28(8):1132-41 - PubMed
  177. Gut. 2014 Aug;63(8):1300-12 - PubMed
  178. Neurogastroenterol Motil. 2006 Oct;18(10):949-56 - PubMed
  179. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3825-9 - PubMed
  180. Br J Pharmacol. 2015 Jan;172(1):142-58 - PubMed
  181. J Mol Med (Berl). 2008 Aug;86(8):925-36 - PubMed
  182. Mol Pharmacol. 1999 Dec;56(6):1362-9 - PubMed
  183. Arch Med Sci. 2017 Oct;13(6):1281-1294 - PubMed
  184. Science. 2005 Dec 2;310(5753):1504-10 - PubMed
  185. Expert Opin Investig Drugs. 2007 Sep;16(9):1405-13 - PubMed
  186. Gastroenterology. 2010 Jun;138(6):2101-2114.e5 - PubMed
  187. Pharmacol Res. 2009 Aug;60(2):117-25 - PubMed
  188. Nature. 2005 Aug 11;436(7052):792 - PubMed
  189. World J Gastroenterol. 2010 Nov 28;16(44):5523-35 - PubMed
  190. FASEB J. 2007 Jun;21(8):1926-33 - PubMed
  191. PLoS One. 2009 Sep 04;4(9):e6893 - PubMed
  192. Trends Pharmacol Sci. 2011 May;32(5):265-9 - PubMed
  193. FASEB J. 2015 Feb;29(2):650-61 - PubMed
  194. Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):691-706 - PubMed
  195. Biochem Pharmacol. 2013 May 1;85(9):1306-16 - PubMed
  196. Cell. 1996 Sep 20;86(6):937-47 - PubMed
  197. Aging Cell. 2013 Apr;12(2):269-79 - PubMed
  198. Int J Mol Sci. 2020 Jul 25;21(15): - PubMed
  199. Nature. 2013 Aug 29;500(7464):541-6 - PubMed
  200. FASEB J. 2006 Mar;20(3):568-70 - PubMed
  201. Trends Endocrinol Metab. 2015 Jun;26(6):273-4 - PubMed
  202. N Engl J Med. 2013 Feb 14;368(7):651-62 - PubMed
  203. J Leukoc Biol. 2003 Oct;74(4):486-96 - PubMed
  204. Sci Rep. 2019 Feb 20;9(1):2358 - PubMed
  205. Fundam Clin Pharmacol. 2002 Aug;16(4):297-302 - PubMed
  206. Anticancer Res. 2011 Nov;31(11):3799-807 - PubMed
  207. World J Gastroenterol. 2015 May 21;21(19):6026-31 - PubMed
  208. Life Sci. 2019 May 1;224:120-127 - PubMed
  209. Front Oncol. 2019 Jan 18;8:643 - PubMed
  210. SAGE Open Med Case Rep. 2019 Feb 21;7:2050313X19832160 - PubMed
  211. J Biol Chem. 2005 Mar 25;280(12):11082-92 - PubMed
  212. Chem Biodivers. 2007 Aug;4(8):1614-48 - PubMed
  213. Gastroenterology. 2009 Feb;136(2):542-50.e6 - PubMed
  214. Oncol Rep. 2015 Jul;34(1):447-54 - PubMed
  215. J Biol Chem. 1997 Feb 7;272(6):3315-23 - PubMed
  216. Neurosci Lett. 1995 Feb 17;186(2-3):91-4 - PubMed
  217. Plant Sci. 2019 Jul;284:67-72 - PubMed
  218. Cell Res. 2011 Oct;21(10):1452-69 - PubMed
  219. Cell Metab. 2013 Apr 2;17(4):475-90 - PubMed
  220. Gut. 2006 Feb;55(2):182-90 - PubMed
  221. Biochim Biophys Acta. 2013 Dec;1833(12):3460-3470 - PubMed
  222. EBioMedicine. 2019 Oct;48:648-655 - PubMed
  223. World J Gastroenterol. 2016 Nov 21;22(43):9515-9524 - PubMed
  224. FASEB J. 2017 Aug;31(8):3267-3277 - PubMed
  225. FASEB J. 2017 Feb;31(2):469-481 - PubMed
  226. Neurogastroenterol Motil. 2015 Oct;27(10):1432-45 - PubMed
  227. Oncogene. 2011 Jan 13;30(2):245-52 - PubMed
  228. Br J Pharmacol. 2016 Jan;173(1):142-54 - PubMed
  229. Int J Neuropsychopharmacol. 2010 Aug;13(7):905-15 - PubMed
  230. Front Pharmacol. 2018 Aug 13;9:889 - PubMed
  231. J Neuroimmunol. 2002 Dec;133(1-2):124-31 - PubMed
  232. J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):348-352 - PubMed
  233. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):123-42 - PubMed
  234. Cell Mol Life Sci. 2011 Aug;68(16):2667-88 - PubMed
  235. J Biol Chem. 2012 Jan 27;287(5):3197-206 - PubMed
  236. Nat Rev Drug Discov. 2018 Sep;17(9):623-639 - PubMed
  237. Lab Invest. 2015 Dec;95(12):1374-86 - PubMed
  238. Cardiovasc Res. 2015 Sep 1;107(4):568-78 - PubMed
  239. Biochem J. 2001 Aug 15;358(Pt 1):249-55 - PubMed
  240. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71 - PubMed
  241. Ann Oncol. 2015 Mar;26(3):463-76 - PubMed
  242. Carcinogenesis. 2013 May;34(5):1150-7 - PubMed
  243. Br J Pharmacol. 2001 Oct;134(4):845-52 - PubMed
  244. Neurogastroenterol Motil. 2016 Dec;28(12):1765-1780 - PubMed
  245. J Neurochem. 2015 Nov;135(4):799-813 - PubMed
  246. Nat Rev Mol Cell Biol. 2002 Jun;3(6):401-10 - PubMed
  247. Oncol Lett. 2015 May;9(5):2056-2062 - PubMed
  248. Gastroenterology. 2016 Apr;150(4):931-43 - PubMed
  249. Bioorg Med Chem Lett. 2016 Aug 15;26(16):3831-7 - PubMed
  250. Cell. 2016 Jul 14;166(2):288-298 - PubMed
  251. FASEB J. 2009 Jan;23(1):183-93 - PubMed
  252. J Oncol Pract. 2019 Apr;15(4):e338-e345 - PubMed
  253. Pathogens. 2019 Aug 13;8(3): - PubMed
  254. Br J Pharmacol. 2007 Nov;152(5):663-70 - PubMed
  255. Cell Signal. 2003 Sep;15(9):851-9 - PubMed
  256. Cell Physiol Biochem. 2018;51(5):2148-2159 - PubMed
  257. Nature. 1996 Nov 7;384(6604):39-43 - PubMed

Publication Types

Grant support